However, there were no significant differences between the three groups in the proportion of patients who had hypertension, type 2 diabetes, dyslipidaemia, cardiovascular disease, or non-alcoholic fatty liver disease, with no differences in the baseline lipid profile and baseline ALT as depicted in Table 1. This evidence concerns the gene GPT and hypertensive disorder.